Amy Tiersten: Clinical Trials

2 trials sponsored by Amy Tiersten, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed. 1 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 11Completed 1
Phase 21Completed 1

Follow Amy Tiersten: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Durvalumab and Eribulin in Her2-negative Metastatic Breast Cancer and Recurrent Ovarian Cancer
Durvalumab, Eribulin - HER2-Negative Metastatic Breast Cancer, Recurrent Ovarian Cancer
Phase 1CompletedAmy Tiersten92018-05-172020-08-05
Comparison of Single-Agent Carboplatin vs the Combination of Carboplatin and Everolimus for the Treatment of Advanced Triple-Negative Breast Cancer
Carboplatin, Everolimus - Breast Cancer
Phase 2CompletedAmy Tiersten642015-12-162025-02-19

Conditions studied

Breast Neoplasms (2)  ·  Ovarian Neoplasms (1)

Interventions

Carboplatin (1)  ·  Everolimus (1)  ·  durvalumab (1)  ·  eribulin (1)

Countries

United States (2)